A Phase I Study of the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib (INLYTA) in Children with Relapsed Refractory Solid Tumors

Grant

Date/time Interval

  • November 18, 2014 - November 17, 2018

    • Awarded By

    Total Award Amount

  • 22500.00

    • Direct Costs

  • 17857.00

    • Sponsor Award Id

    • Contributor

  • Ana Galtarossa Xavier   Investigator